Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: SELLAS Life Sciences (SLS)
Production automation and AI-driven drug modeling are creating financial pressure, which is evident in the EBITDA growth trajectory displayed on GURU.Markets; meanwhile, the value of 0.00 reflects the metric's balance. Patents and vaccine royalties provide stability, yet the survival of SELLAS Life Sciences (SLS) currently depends on the results of Phase III leukemia trials due to a critical decline in capital.
Ringkesan rincian data analitis SELLAS Life Sciences Group (SLS)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal SELLAS Life Sciences|SLS - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas SELLAS Life Sciences Group, Inc.|SLS - Utang perusahaan|Rasio utang marang kapitalisasi buku SELLAS Life Sciences|SLS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan SELLAS Life Sciences|Koefisien jangkoan perantara sellaslifesciences.com
- rincian bathi lan kelipatan pasar:
SLS - Penghasilan resik|Penghasilan resik sing dikarepake SELLAS Life Sciences|SLS - Rasio rega marang bathi|Rega marang bathi mangsa ngarep SELLAS Life Sciences Group, Inc.|SLS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan SELLAS Life Sciences|SLS - Bathi operasional EBITDA|Bathi saben siji saham sajrone 12 wulan pungkasan SELLAS Life Sciences|SLS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan sellaslifesciences.com|SLS - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep SELLAS Life Sciences
Analisis kabeh metrik perusahaan:SELLAS Life Sciences (SLS)
For SELLAS Life Sciences (SLS), which is developing alliances with oncology centers to create immunotherapeutic vaccines, the projected EBITDA level serves as an indicator of operational management efficiency. This metric reflects cash flow before depreciation and interest, allowing investors to assess the business's actual ability to generate cash and determine capital stability through the analysis of historical extremes without the risk of overpaying for the asset.
Karo sapa SELLAS Life Sciences saingan
Bathi operasional EBITDA BeiGene Oncology ONC|HALO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RVMD (revmed.com)|AAPG: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi CG Oncology Inc (CGON)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi UroGen|Bicara Corp (BCAX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA PSNL|ERAS - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Delcath Systems DCTH|Y-mAbs Therapeutics Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CADL: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ARAY: Bathi operasional EBITDA|actuatetherapeutics.com (ACTU) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Citius Oncology|TuHURA (HURA) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi TARA (Protara)|FATE (Fate Pharma) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aadi Bioscience WHWK|TScan Therapeutics Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Champions Oncology Corp - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi XBiotech Inc. XBIT|CVM: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi OSTX (OS Therapies, Inc.)|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Artiva ARTV|Bathi operasional sadurunge ngurangi amortisasi ANL (Adlai Nortye Ltd.)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Pendapatan operasional sadurunge ngurangi amortisasi Xilio Therapeutics Inc (XLO)|Enochian BioSciences - Bathi operasional EBITDA|Mural Oncology plc (MURA) - Bathi operasional sadurunge ngurangi amortisasi|KAPA: Bathi operasional EBITDA|OKUR - Pendapatan operasional sadurunge ngurangi amortisasi|GDTC (CytoMed Therapeutics Ltd) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Curis Corp CRIS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Apollomics, Inc. (APLM)|tharimmune.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA ADVB (Advanced Biomed)|GNPX - Bathi operasional sadurunge ngurangi amortisasi|Calidi Bio - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi sunshinebiopharma.com|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Purple Biotech Ltd.|AON (AONC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BeOne Medicines (BGNE)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CKPT (Checkpoint Therapeutics Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|Pendapatan operasional sadurunge ngurangi amortisasi iCAD Inc. (ICAD)|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|MorphoSys Corporation (MOR) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|Bathi operasional sadurunge amortisasi AAPGV (ascentage.com)
